Litigation Details for Forest Laboratories LLC v. InvaGen Pharmaceuticals Inc. (D. Del. 2015)
✉ Email this page to a colleague
Forest Laboratories LLC v. InvaGen Pharmaceuticals Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-03-27 |
| Court | District Court, D. Delaware | Date Terminated | 2017-10-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 7,834,020; 8,193,195; 8,236,804; 8,673,921 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Forest Laboratories LLC v. InvaGen Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Forest Laboratories LLC v. InvaGen Pharmaceuticals Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-20 | 105 | asserted claims of U.S. Patent Nos. 7,834,020 ("the '020 patent"), 8,193,195 ("the…that because claim 1 of U.S. Patent No. 7,834,020, claim 1 of U.S. Patent No. 8,236,804, and claims 5,… ORDER CONSTRUING THE TERMS of U.S. Patent Nos. 7,834,020, 8,193,195, 8,236,804, and 8,673,921. Signed…CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,834,020, 8,193,195, 8,236,804, AND 8,673,921 …the patent. '020 patent, col. 27 ll.42-43; '804 patent, col. 28, 1. 1; '921 patent, col | External link to document | |
| 2017-05-02 | 141 | for infringement ofU.S. Patent Nos. 7,834,020 (''the '020 Patent"), 8,193,195 ('…;'the '195 Patent"), 8,236,804 (''the '804 Patent"), and 8,673,921… (''the '921 Patent") (collectively the "Patents in Suit") in connection…the expiration of the Patents in Suit was an act of infringement of the Patents in Suit under 35 U.S.…HOLDINGS, LTD., MERCK ) KGaA and MERCK PATENT GESELLSCHAFT ) MIT BESCHRANKTER | External link to document | |
| 2015-03-27 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,834,020; 8,193,195; 8,236,804…2015 24 October 2017 1:15-cv-00272 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-06-22 | 86 | other disorders. The patents-in-suit are U.S. Patent Nos. 7,834,020 (the “ ’020 patent”), 8,193,195 (the…the “ ’195 patent”), 8,236,804 (the “ ’804 patent”), and 8,673,921 (the “ ’921 patent”). While Forest … the ’020 patent, claim 1 of the ’804 patent, and claims 5, 11, and 13 of the ’921 patent, “crystalline…admits that a prior art patent, U.S. Patent No. 5,532,241 (the “ ’241 patent”), discloses vilazodone …804 Patent. The PTO rejected claim 1 of the ’804 patent as anticipated by the ’241 patent. See | External link to document | |
| 2016-06-22 | 87 | licensee of U.S. Patent Nos. 7,834,020 (“the ’020 patent”); 8,193,195 (“the ’195 patent”); 8,236,804 (“…(“the ’804 patent”); and 8,673,921 (“the ’921 patent”) (collectively, “the patents-in-suit”), which are… U.S. Patent No. 5,532,241 (“’241 patent”), which is incorporated by reference in the patents-in- …Merck Patent Gesellschaft mit beschränkter Haftung (collectively, “Merck”). The patents-in-suit…including major 1 The patents-in-suit all claim priority to a June 2001 patent application. | External link to document | |
| 2016-06-22 | 88 | infringed U.S. Patent Nos. 7,834,020 (the “’020 patent”), 8,193,195 (the “’195 patent”), 8,236,804 (the…22/16 Page 2 of 18 PageID #: 768 patent”) (collectively, “patents-in-suit”), by filing Abbreviated New… not present. VII. THE PATENTS-IN-SUIT 27. The patents-in-suit describe the invention…., ‘804 patent, col. 2, l. 39 to col. 3, l. 30; col. 5, ll. 1-22. Additionally, during patent prosecution…Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Attachments | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
